Get started
Author

Christiane Modeß

Observed names: C MODESS, C Modess, C. Modess, Christiane Modess, Modess, Christiane
OpenAlex ID: A5028540012
Carbamazepine regulates intestinal P-glycoprotein and multidrug resistance protein MRP2 and influences disposition of talinolol in humans
2004 · T GIESSMANN, K MAY, et al. · Clinical Pharmacology & Therapeutics · 168
Replacement therapy with levothyroxine plus triiodothyronine (bioavailable molar ratio 14 : 1) is not superior to thyroxine alone to improve well‐being and cognitive performance in hypothyroidism
2004 · W. Siegmund, K. Spieker, et al. · Clinical Endocrinology · 153
Visualization of Hepatic Uptake Transporter Function in Healthy Subjects by Using Gadoxetic Acid–enhanced MR Imaging
2012 · Ali Nassif, Jia Jia, et al. · Radiology · 149
CYP2D6genotype and induction of intestinal drug transporters by rifampin predict presystemic clearance of carvedilol in healthy subjects
2004 · Thomas Giessmann, Christiane Modess, et al. · Clinical Pharmacology & Therapeutics · 129
Resolving the physiological conditions in bioavailability and bioequivalence studies: Comparison of fasted and fed state
2016 · Felix Schneider, Michael Grimm, et al. · European Journal of Pharmaceutics and Biopharmaceutics · 96
Targeted adsorption of molecules in the colon with the novel adsorbent‐based Medicinal Product, DAV132: A proof of concept study in healthy subjects
2014 · Jean de Gunzburg, Annie Ducher, et al. · The Journal of Clinical Pharmacology · 71
The Talinolol Double-Peak Phenomenon Is Likely Caused by Presystemic Processing After Uptake from Gut Lumen
2005 · Werner Weitschies, Annika Bernsdorf, et al. · Pharmaceutical Research · 69
Propranolol selectively blocks the enhanced parietal old/new effect during long-term recollection of unpleasant pictures: A high density ERP study
2009 · Mathias Weymar, Andreas Löw, et al. · NeuroImage · 47
Simvastatin does not influence the intestinal P‐glycoprotein and MPR2, and the disposition of talinolol after chronic medication in healthy subjects genotyped for the ABCB1, ABCC2 and SLCO1B1 polymorphisms
2006 · Annika Bernsdorf, Thomas Giessmann, et al. · British Journal of Clinical Pharmacology · 45
Compartment-Specific Gene Regulation of the CAR Inducer Efavirenz In Vivo
2012 · H E Meyer zu Schwabedissen, S Oswald, et al. · Clinical Pharmacology & Therapeutics · 43
Impact of Efavirenz on Intestinal Metabolism and Transport: Insights From an Interaction Study With Ezetimibe in Healthy Volunteers
2012 · S Oswald, H E Meyer zu Schwabedissen, et al. · Clinical Pharmacology & Therapeutics · 43
Metabolic activation and analgesic effect of flupirtine in healthy subjects, influence of the polymorphic NAT2, UGT1A1 and GSTP1
2014 · Werner Siegmund, Christiane Modess, et al. · British Journal of Clinical Pharmacology · 31
Pharmacokinetic and Pharmacodynamic Interactions Between the Immunosuppressant Sirolimus and the Lipid-Lowering Drug Ezetimibe in Healthy Volunteers
2010 · S Oswald, A Nassif, et al. · Clinical Pharmacology & Therapeutics · 26
Effects of anxiety sensitivity and expectations on the modulation of the startle eyeblink response during a caffeine challenge
2015 · Christoph Benke, Terry D. Blumenthal, et al. · Psychopharmacology · 20
Extended‐release but not immediate‐release and subcutaneous methylnaltrexone antagonizes the loperamide‐induced delay of whole‐gut transit time in healthy subjects
2015 · Julia Kolbow, Christiane Modess, et al. · The Journal of Clinical Pharmacology · 19
Drug Interactions Between the Immunosuppressant Tacrolimus and the Cholesterol Absorption Inhibitor Ezetimibe in Healthy Volunteers
2011 · S Oswald, A Nassif, et al. · Clinical Pharmacology & Therapeutics · 17
Pharmacokinetic Drug‐Drug Interactions Between Trospium Chloride and Ranitidine Substrates of Organic Cation Transporters in Healthy Human Subjects
2019 · Bayew Tsega Abebe, Michael Weiss, et al. · The Journal of Clinical Pharmacology · 15
PDF
Trospium chloride is absorbed from two intestinal “absorption windows” with different permeability in healthy subjects
2016 · Tobias Tadken, Michael Weiss, et al. · International Journal of Pharmaceutics · 14
Chiral Pharmacokinetics and Metabolite Profile of Prolonged-release Ketamine Tablets in Healthy Human Subjects
2021 · Mahmoud Hasan, Christiane Modess, et al. · Anesthesiology · 13
Anxiety sensitivity and expectation of arousal differentially affect the respiratory response to caffeine
2014 · Christiane A. Pané-Farré, Manuela G. Alius, et al. · Psychopharmacology · 13
Oral absorption of propiverine solution and of the immediate and extended release dosage forms: influence of regioselective intestinal elimination
2008 · Karen May, Thomas Giessmann, et al. · European Journal of Clinical Pharmacology · 13
Muscle Injury After Intramuscular Administration of Diclofenac: A Case Report Supported by Magnetic Resonance Imaging
2017 · Mareike Probst, Jens-Peter Kühn, et al. · Drug Safety - Case Reports · 12
PDF
Effects of the P‐Glycoprotein Inhibitor Clarithromycin on the Pharmacokinetics of Intravenous and Oral Trospium Chloride: A 4‐Way Crossover Drug‐Drug Interaction Study in Healthy Subjects
2019 · Bayew Tsega Abebe, Michael Weiss, et al. · The Journal of Clinical Pharmacology · 9
Replacement therapy with thyroxine plus triiodothyronine (14:1) is not superior to thyroxine alone with respect to the psychical and physical wellbeing of patients with hypothyroidism
2004 · W Meng, K Spieker, et al. · Experimental and Clinical Endocrinology & Diabetes · 1
Dose-Dependent Pharmacokinetics and Metabolisms of Prolonged-Release Ketamine Tablets in Healthy Subjects
2017 · M. Hasan, C. Modess, et al. · Clinical Therapeutics
PDF
Works count: 26
Citation count: 1,216
H-index: 16
I10-index: 22
Year
Topic
Type